Melissa.Moore
@mooreorless62
CSO, Moderna Therapeutics, RNA expert
Hurricane Maria's Death Toll Was Decades In The Making huffingtonpost.com/entry/opinion-…
This chief scientific officer at Moderna breaks down the misunderstandings about the mRNA in the COVID-19 vaccine, and explains how it could change the world (via @TEDTalks)
Today we welcome world leaders in #RNA research and therapeutics to our SAB. We will work with them to harness the power of #tRNA biology to advance a single medicine with the potential to treat thousands of diseases. Release: bit.ly/3iaFZFG bit.ly/3i6SfqC
I’m very excited to be part of this new company!
We are Alltrna, the world’s first #tRNA platform company. We are harnessing the power of #tRNAbiology to create a new class of #programmablemedicines with the potential to treat thousands of diseases. alltrna.com @FlagshipPioneer #tRNAtherapeutics #machinelearning
The pace of progress in medicine is moving at record speed. Discover how Nasdaq-100 listed Moderna is accelerating innovation to meet unmet medical needs.
Apparently I’ve been referenced on @nbcsnl by @MayaRudolph? I just woke up to a ton of text messages
We just announced that mRNA-1273, our COVID-19 vaccine candidate, has met its primary efficacy endpoint in the first interim analysis of the Phase 3 COVE study. Read more: buff.ly/3puVGK6
We just announced a longer shelf life at refrigerated temperatures for mRNA-1273, our COVID-19 vaccine candidate. Read more: buff.ly/3f2RE6V
Announcing the exciting PROGRAM of the 8th International #mRNA Health Conference! Comprehensive topics will be presented including a special focus on #COVID19 #vaccines! mrna-conference.com/program-speake…
Forward-Looking Information and Factors That May Affect Future Results businesswire.com/news/home/2020…
Congratulations @Alnylam! A great day for the entire RNA therapeutics community!
Today’s @US_FDA approval of GIVLAARI is a defining moment for @Alnylam as we become a multi-product commercial company, for the field of #RNAi with the 1st ever approved GalNAc-conjugate RNAi tx & most importantly, for #raredisease patients awaiting a new treatment option.
Happy Mole Day everyone! images.app.goo.gl/BRNiX9SK611eKG…
Thank you IUBMB!
Congratulations to Melissa Moore, Moderna Therapeutics @moderna_tx, for being named IUBMB Jubilee Lecturer at the RNA Society 2020 meeting in beautiful Vancouver, Canada. This award recognizes her outstanding contributions to RNA biology and therapeutics. @RNASociety @CSMB_SCBM
The perfect piece of #Modernart for #RNADay @moderna_tx! Long live our polysome!
The perfect wine for a spliceosome enthusiast on #RNADay! Thanks @sainiharleen! Or should I say Dr. Saini?
Moderna Announces an Array of Clinical Advances and Outlines 2018 Priorities; 19 Development Candidates, including 10 Clinical Programs, Highlight Productivity of mRNA Platform dlvr.it/Q9QLq3
Moderna #JPM18 450m$ invested in R&D in 2017... pipeline below: 19 candidates, 10 clinical trials
Moderna to start phase II trial of @AstraZeneca-partnered VEGF project “in matter of weeks”, says Stephane Bancel #JPM18
Standing room only for Moderna’s presentation #JPM18